Takeda Pharmaceutical Company Limited Number Of Share Options Exercised In Share-based Payment Arrangement
Takeda Pharmaceutical Company Limited (TAK) reported Number Of Share Options Exercised In Share-based Payment Arrangement of 12.00 thousand shares for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement · last filed 2025-06-25
| Period end | Number Of Share Options Exercised In Share-based Payment Arrangement 12 month |
|---|---|
| 2025-03-31 | 12.00K shares 20-F · filed 2025-06-25 |
| 2024-03-31 | 122.70K shares 20-F · filed 2025-06-25 |
| 2023-03-31 | 43.50K shares 20-F · filed 2025-06-25 |
| 2022-03-31 | 10.10K shares 20-F · filed 2024-06-26 |
| 2021-03-31 | 14.00K shares 20-F · filed 2023-06-28 |
| 2020-03-31 | 18.00K shares 20-F · filed 2022-06-29 |
| 2019-03-31 | 14.60K shares 20-F · filed 2021-06-29 |
| 2018-03-31 | 617.10K shares 20-F · filed 2020-06-24 |
| 2017-03-31 | 237.10K shares 20-F · filed 2019-06-27 |